Drugs: A

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z #

ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

0 identified pills

ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HYDROBROMIDE TABLET, COATED

Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

0 identified pills

ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL

Expectorant [EPC]

0 identified pills

ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN, IBUPROFEN

Nonsteroidal Anti-inflammatory Drug [EPC]; Cyclooxygenase Inhibitors [MoA]

0 identified pills

ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE

0 identified pills

ACETAMINOPHEN, PHENYLEPHRIN HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE

Expectorant [EPC]

0 identified pills

ACETAMINOPHEN, PHENYLEPHRINE HCL

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN, PHENYLEPHRINE HCL, DEXTROMETHORPHAN HBR, GUAIFENESIN

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE

Adrenergic alpha1-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE

Adrenergic alpha-Agonists [MoA]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN,DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN,DEXTROMETHORPHAN HYDROBROMIDE,GUAIFENESIN,PHENYLEPHRINE HYDROCHLORIDE

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN-DEXTROMETHORPHAN HBR-PHENYLEPHRINE HCL-CHLORPHENIRAMINE MALEATE

Adrenergic alpha1-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACETAMINOPHEN-PHENYLEPHRINE HYDROCHLORIDE-CHLORPHENIRAMINE MALEATE

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

0 identified pills

ACETAMINPHEN

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

0 identified pills

ACONITUM NAPELLUS

0 identified pills

ADEFOVIR DIPIVOXIL

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

0 identified pills

AFICAMTEN

0 identified pills

ALBUTEROL SULFATE

Adrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]

0 identified pills

ALECTINIB HYDROCHLORIDE

Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

0 identified pills

ALENDRONATE SODIUM

Bisphosphonate [EPC]; Diphosphonates [CS]

0 identified pills

ALENDRONATE SODIUM and CHOLECALCIFEROL

Bisphosphonate [EPC]; Diphosphonates [CS]; Vitamin D [CS]; Vitamin D [EPC]

0 identified pills

ALFUZOSIN HYDROCHLORIDE

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

0 identified pills

ALISKIREN

Renin Inhibitor [EPC]; Renin Inhibitors [MoA]

0 identified pills

ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Skin Barrier Activity [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

0 identified pills

AMANTADINE HYDROCHLORIDE

Influenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]

0 identified pills

AMBRISENTAN

Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]

0 identified pills

AMITRIPTYLINE HYDROCHLORIDE

Tricyclic Antidepressant [EPC]

0 identified pills

AMLODIPINE BESYLATE

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]

0 identified pills

AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE

Thiazide Diuretic [EPC]; Angiotensin 2 Receptor Blocker [EPC]; Angiotensin 2 Receptor Antagonists [MoA]

0 identified pills

AMOXICILLIN AND CLAVULANATE POTASSIUM

beta Lactamase Inhibitor [EPC]; beta Lactamase Inhibitors [MoA]

0 identified pills

AMOXICILLIN/CLAV POT

Penicillin-class Antibacterial [EPC]; Penicillins [CS]; beta Lactamase Inhibitor [EPC]; beta Lactamase Inhibitors [MoA]

0 identified pills

ANAGRELIDE

Decreased Platelet Production [PE]; Phosphodiesterase 3 Inhibitors [MoA]; Platelet-reducing Agent [EPC]

0 identified pills

ANASTROZOLE

Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]

0 identified pills

ANHYDROUS CITRIC ACID, ASPIRIN

Anti-Inflammatory Agents; Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

0 identified pills

ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE

Acidifying Activity [MoA]; Alkalinizing Activity [MoA]; Anti-Inflammatory Agents; Non-Steroidal [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Cyclooxygenase Inhibitors [MoA]; Decreased Coagulation Factor Activity [PE]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]

0 identified pills

ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED)

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]

0 identified pills

ANTACID AND ANTIGAS

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Skin Barrier Activity [PE]

0 identified pills

ANTACID CALCIUM CARBONATE

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]

0 identified pills

ANTACID TABLETS

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]

0 identified pills

APREPITANT

Substance P/Neurokinin-1 Receptor Antagonist [EPC]; Neurokinin 1 Antagonists [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]

0 identified pills

ARIPIPRAZOLE ORALLY DISINTEGRATING

Atypical Antipsychotic [EPC]

0 identified pills

ARNICA MONTANA

0 identified pills

ARNICA MONTANA 6x

0 identified pills